TAOX Tao Synergies Inc.
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
What changed
Recent filings, trades and moves- Nov 13 Reports earnings

- Industry (SIC)
- FINANCE SERVICES (6199) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 4
- List Date
- 2020-12-07
- CIK
- 0001571934
- Next Earnings
- 2026-11-13
- Headquarters
- New York, NY
- Homepage
- https://www.taosynergies.com
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '25 | '26 | Avg |
|---|---|---|---|
| Jan | -- | -3.61% | -3.61% |
| Feb | -- | -5.33% | -5.33% |
| Mar | -- | 36.45% | 36.45% |
| Apr | -- | -10.47% | -10.47% |
| May | -- | -21.20% | -21.20% |
| Jun | -- | -11.40% | -11.40% |
| Jul | -24.19% | -6.00% | -15.10% |
| Aug | -2.84% | 7.92% | 2.54% |
| Sep | 5.48% | 17.97% | 11.72% |
| Oct | 37.95% | -35.54% | 1.21% |
| Nov | -4.41% | 8.15%* | 1.87% |
| Dec | -39.47% | -- | -39.47% |
| Total | -37.99% | -35.07% | -36.53% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report: TAOX
Executive Summary:
BULLISH (Confidence Level: 7/10)
Key drivers: Bullish momentum signals from MACD, technical trends aligning with recent price action.
Primary risks: High volatility, beta above market average, potential for sudden price movements.
Investment thesis: TAOX is likely to continue its upward trend in the short-term (1-4 weeks), driven by bullish momentum and positive technical signals. However, high volatility and beta above market average pose significant risks.
Recent news sentiment impact: No recent news available, which reduces the impact of external factors on the stock's price movement.
Technical Analysis:
Trend Direction: Short-term: Uptrend (1-4 weeks), Medium-term: Neutral (1-3 months), Long-term: Downtrend (3-12 months)
Support/Resistance Levels: Key levels to monitor include SMA 20 ($3.81) and the upper Bollinger Band ($4.33).
Momentum Signals:
- RSI interpretation: Neutral (52.78)
- MACD signal: Bullish (crossover above signal line)
- Bollinger Bands position: Squeeze, indicating potential breakout
Volume Analysis: Volume trends are mixed, with a slight increase in volume over the past few days.
News & Sentiment Analysis:
Recent Headlines Summary: No recent news available.
Sentiment Assessment: Neutral due to lack of recent news.
Catalyst Identification: No immediate catalysts identified.
Market Narrative: The stock's price movement is primarily driven by technical signals, with no significant external factors influencing its behavior at this time.
Risk & Volatility Assessment:
Beta Interpretation: High risk (beta above market average).
Volatility Regime: High volatility, with a True Range of $0.25 and an ATR of $0.33.
Options Market Signals: No options data available to analyze.
Downside Protection: Support levels include SMA 20 ($3.81) and the lower Bollinger Band ($3.30).
Market Context & Positioning:
Sector Performance: TAOX is trading within its sector's average volatility range.
Institutional Activity: No clear institutional activity patterns identified.
Correlation Analysis: Correlation with the market (SPY) is moderate, at 0.43.
Relative Valuation: The stock is positioned in a trading range, with no clear relative valuation signal.
Key Levels & Action Items:
Critical Price Levels: SMA 20 ($3.81) and the upper Bollinger Band ($4.33).
Breakout/Breakdown Levels: A breakout above $4.33 or a breakdown below $3.30 could trigger significant price movements.
Time-Sensitive Catalysts: No immediate catalysts identified, but earnings data may become available in the near future.
Risk Management: Consider setting stop-loss levels around SMA 20 ($3.81) and adjusting position sizing according to market conditions.
Please note that this report is based on the provided data and should not be used as a basis for making investment decisions without further analysis and consideration of additional factors.
TAOX Options Activity & IV Rank
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Loading the implied volatility surface…
Loading the implied volatility smile…
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
High volatility - stock moves more than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $310K | #5025 of 6285 | new | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $294K | #2782 of 3138 | -22.6% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
TAOX Institutional Ownership (13F)
Filings for 2026-06-30 · 9 already for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
TAOX Insider Trading (Form 4)
Latest: 2026-05-19| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | Robert Ephron | Director | Grant (A) | +10,000 opt | — | EDGAR | |
| 2026-05-19 | William S. Singer | Director | Grant (A) | +35,000 opt | — | EDGAR | |
| 2026-05-19 | Joshua Silverman | Executive Chairman | Grant (A) | +200,000 opt | — | EDGAR | |
| 2026-05-19 | Robert Weinstein | Chief Financial Officer | Grant (A) | +30,000 opt | — | EDGAR | |
| 2026-05-19 | Bruce Bernstein | Director | Grant (A) | +55,000 opt | — | EDGAR | |
| 2026-04-08 | Robert Ephron | Director | Grant (A) | +800 opt | — | EDGAR | |
| 2026-04-08 | William S. Singer | Director | Grant (A) | +800 opt | — | EDGAR | |
| 2026-04-08 | Bruce Bernstein | Director | Grant (A) | +800 opt | — | EDGAR | |
| 2025-10-17 | Robert Ephron | Director | Mixed Tax −3,000 · Grant +7,500 |
+4,500 | $7.23 | -$21.7K | EDGAR |
| 2025-10-17 | Joshua Silverman | Executive Chairman | Mixed Tax −40,000 · Grant +100,000 |
+60,000 | $7.23 | -$289.2K | EDGAR |
| 2025-10-17 | Jonathan Schechter | Director | Grant (A) | +10,000 opt | — | EDGAR | |
| 2025-10-17 | William S. Singer | Director | Mixed Grant +15,000 · Tax −6,000 |
+9,000 | $7.23 | -$43.4K | EDGAR |
| 2025-10-17 | Bruce Bernstein | Director | Mixed Grant +25,000 · Tax −10,000 |
+15,000 | $7.23 | -$72.3K | EDGAR |
| 2025-10-17 | Robert Weinstein | Chief Financial Officer | Mixed Grant +10,000 · Tax −4,000 |
+6,000 | $7.23 | -$28.9K | EDGAR |
| 2025-07-02 | Alan J Tuchman | Chief Medical Officer | Mixed Grant +4,315 · Tax −1,726 |
+2,589 | $7.85 | -$13.5K | EDGAR |
TAOX Insider Holdings
7 insiders · @ $2.72| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Joshua Silverman | Executive Chairman | 126,681 | $344.6K | $0 | 3 | 2026-05-19 |
| 2 | Bruce Bernstein | Director | 30,897 | $84.0K | $0 | 4 | 2026-05-19 |
| 3 | William S. Singer | Director | 19,566 | $53.2K | $0 | 4 | 2026-05-19 |
| 4 | Robert Weinstein | Chief Financial Officer | 16,574 | $45.1K | $0 | 3 | 2026-05-19 |
| 5 | Jonathan Schechter | Director | 14,035 | $38.2K | $0 | 2 | 2025-10-17 |
| 6 | Robert Ephron | Director | 7,500 | $20.4K | $0 | 3 | 2026-05-19 |
| 7 | Alan J Tuchman | Chief Medical Officer | 3,909 | $10.6K | $0 | 1 | 2025-07-02 |
TAOX Board & Officers
As of SEC filings through May 19, 2026Directors 4
- Bruce Bernstein · since Jun 4, 2021
- Joshua Silverman · since Jun 4, 2021
- William S. Singer · since Jun 4, 2021
- Robert Ephron · since Aug 29, 2025
Officers 2
- Robert Weinstein · Chief Financial Officer · since Jun 4, 2021
- Joshua Silverman · Executive Chairman · listed since Jul 2025
Changes in the last 10 years (17)
| Feb 5, 2026 | Alan J Tuchman reported in an SEC filing no longer being a director |
| Feb 5, 2026 | Alan J Tuchman reported in an SEC filing no longer being Chief Executive Officer |
| Aug 29, 2025 | Robert Ephron became a director |
| Aug 28, 2025 | The company announced the departure of Jonathan Schechter from the board in an SEC filing |
| Jul 2, 2025 | Joshua Silverman first listed as Executive Chairman in an SEC filing |
| Dec 1, 2022 | Daniel L. Alkon listed as President and CSO (previously President and Chief Scientific Officer) in SEC filings |
| Jul 15, 2021 | Daniel L. Alkon listed as President and Chief Scientific Officer (previously Chief Scientific Officer) in SEC filings |
| Jun 4, 2021 | William S. Singer became a director |
| Jun 4, 2021 | Robert Weinstein became Chief Financial Officer |
| Jun 4, 2021 | Joshua Silverman became a director |
| Jun 4, 2021 | Jonathan Schechter became a director |
| Jun 4, 2021 | George Perry became a director |
| Jun 4, 2021 | Daniel L. Alkon became a director |
| Jun 4, 2021 | Daniel L. Alkon became Chief Scientific Officer |
| Jun 4, 2021 | Bruce Bernstein became a director |
| Jun 4, 2021 | Alan J Tuchman became a director |
| Jun 4, 2021 | Alan J Tuchman became Chief Executive Officer |
Not reported recently (2)
- Daniel L. Alkon · Last reported as a director in an SEC filing dated Dec 20, 2023
- George Perry · Last reported as a director in an SEC filing dated Jul 15, 2021
| Filing Date | Event | Link |
|---|
| Filing Date | Accession | Link |
|---|
| Filing Date | Accession | Link |
|---|---|---|
| 2026-08-13 | 0001104659-26-095966 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $358,318 | — | 2026-09-30 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $337,902 | — | 2026-09-30 |
| 3 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.00% | $56,573 | $1.2B | 2026-11-06 |
| 4 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.00% | $1,876 | — | 2026-11-05 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
TAOX vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| AXP American Express Company | $215.2B | 18.3 | +8.7% | −13.0% | 29 |
| NU Nu Holdings Ltd. | $58.1B | — | — | −27.4% | 48 |
| MSTR Strategy Inc Common Stock Class A | $54.5B | — | +0.4% | −20.1% | 37 |
| COIN Coinbase Global, Inc. Class A Common Sto | $35.7B | — | −26.6% | −42.5% | 35 |
| SYF SYNCHRONY FINANCIAL | $24.0B | 7.6 | +0.5% | −13.5% | 45 |
| SOFI SoFi Technologies, Inc. Common Stock | $21.0B | 37.2 | +78.6% | −39.0% | 21 |
| CRCL Circle Internet Group, Inc. | $17.4B | 34.6 | +46.0% | −19.1% | 20 |
| COOP Mr. Cooper Group Inc. Common Stock | $13.5B | — | — | +0.0% | — |
| TAOX Tao Synergies Inc. Common Stock | $20M | — | — | −38.6% | — |
| Peer median | $29.8B | 26.5 | +4.6% | −19.6% | 35 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.